Karakteristik Tingkat Nyeri pada Pasien Gout Arthritis
DOI:
https://doi.org/10.37287/jlh.v7i2.2485Keywords:
gout arthritis, lansia, numeric rating scale, pelayanan kesehatan primer, tingkat nyeriAbstract
Gout arthritis merupakan salah satu penyakit inflamasi sendi yang prevalensinya terus meningkat di berbagai negara. Nyeri merupakan manifestasi klinis utama yang berdampak terhadap aktivitas sehari-hari, kualitas tidur, kemampuan fungsional, serta kualitas hidup penderita. Meskipun berbagai penelitian telah membahas faktor risiko dan penatalaksanaan gout arthritis, informasi mengenai karakteristik tingkat nyeri pasien pada pelayanan kesehatan primer di Indonesia masih terbatas. Tujuan untuk mengetahui karakteristik tingkat nyeri pada pasien gout arthritis di wilayah kerja UPTD Puskesmas 1 Baturetno Wonogiri. Penelitian deskriptif kuantitatif dengan pendekatan cross-sectional dilakukan pada 62 responden yang dipilih menggunakan teknik purposive sampling dari total populasi 196 pasien gout arthritis. Tingkat nyeri diukur menggunakan Numeric Rating Scale (NRS). Analisis data dilakukan secara deskriptif menggunakan distribusi frekuensi dan persentase. Mayoritas responden berusia lebih dari 60 tahun (54,8%), berjenis kelamin perempuan (56,5%), serta telah menderita gout arthritis selama ≥5 tahun (67,7%). Tingkat nyeri terbanyak adalah nyeri sedang (43,5%), diikuti nyeri berat (38,7%) dan nyeri ringan (17,7%). Sebagian besar pasien gout arthritis mengalami nyeri sedang dengan karakteristik dominan usia lanjut, perempuan, dan lama menderita penyakit ≥5 tahun.
References
Ahn, E. Y., & So, M. W. (2025). The pathogenesis of gout. Journal of Rheumatic Diseases, 32(1), 8–16. https://doi.org/10.4078/jrd.2024.0054
Asghari, K. M., Zahmatyar, M., Seyedi, F., Motamedi, A., Zolfi, M., Alamdary, S. J., Fazlollahi, A., Shamekh, A., Mousavi, S. E., Nejadghaderi, S. A., Mohammadinasab, R., Ghazi-Sha’rbaf, J., Karamzad, N., Sullman, M. J. M., Kolahi, A.-A., & Safiri, S. (2024). Gout: Global epidemiology, risk factors, comorbidities and complications: a narrative review. BMC Musculoskeletal Disorders, 25(1), 1047. https://doi.org/10.1186/s12891-024-08180-9
Bolognesi, A., Bortolotti, M., Battelli, M. G., & Polito, L. (2024). Gender Influence on XOR Activities and Related Pathologies: A Narrative Review. Antioxidants, 13(2), 211. https://doi.org/10.3390/antiox13020211
Du, L., Zong, Y., Li, H., Wang, Q., Xie, L., Yang, B., Pang, Y., Zhang, C., Zhong, Z., & Gao, J. (2024). Hyperuricemia and its related diseases: Mechanisms and advances in therapy. Signal Transduction and Targeted Therapy, 9(1), 212. https://doi.org/10.1038/s41392-024-01916-y
Gorayan Alrowaili, M., A. Badawy, A., Aiad Tuaysan Alenezi, Y., Qadhab Mater Alruwaili, M., Mohammed Malooh, A., Nazal Idrees Alanazi, A., Bader Nassif Alenezi, A., Abd-Alhadi Jaban Aldahmshi, O., & Abd El Mawgod, M. M. (2025). Public Awareness and Perceptions of Gout Risk and Prevention in Northern Saudi Arabia: A Cross-Sectional Study. Journal of Pioneering Medical Sciences, 14(04), 78–80. https://doi.org/10.47310/jpms2025140410
Jin, S., Wang, Y., Yan, S., Fu, X., Hu, X., Lyu, Z., & Liu, H. (2025). Global burden and trends of gout incidence and prevalence. Chinese Medical Journal, 138(23), 3153–3162. https://doi.org/10.1097/CM9.0000000000003631
Leask, M. P., Crișan, T. O., Ji, A., Matsuo, H., Köttgen, A., & Merriman, T. R. (2024). The pathogenesis of gout: Molecular insights from genetic, epigenomic and transcriptomic studies. Nature Reviews Rheumatology, 20(8), 510–523. https://doi.org/10.1038/s41584-024-01137-1
Lee, J., Sumpter, N., Merriman, T. R., Liu-Bryan, R., & Terkeltaub, R. (2023). The Evolving Landscape of Gout in the Female: A Narrative Review. Gout, Urate, and Crystal Deposition Disease, 2(1), 1–16. https://doi.org/10.3390/gucdd2010001
Putri, S. Q. D., Rahmayanti, D., & Diani, N. (2017). PENGARUH PEMBERIAN KOMPRES JAHE TERHADAP INTENSITAS NYERI GOUT ARTRITIS PADA LANSIA DI PSTW BUDI SEJAHTERA KALIMANTAN SELATAN. Dunia Keperawatan, 5(2), 90. https://doi.org/10.20527/dk.v5i2.4112
Raya-Cano, E., Vaquero-Abellán, M., Molina-Luque, R., De Pedro-Jiménez, D., Molina-Recio, G., & Romero-Saldaña, M. (2022). Association between metabolic syndrome and uric acid: A systematic review and meta-analysis. Scientific Reports, 12(1), 18412. https://doi.org/10.1038/s41598-022-22025-2
Richette, P., & Dalbeth, N. (2024). Treat-to-target or treat-to-dissolve strategy to improve gout treatment. Nature Reviews Rheumatology, 20(7), 393–394. https://doi.org/10.1038/s41584-024-01117-5
Shanmugam, K. T., Chan, I., & Morandi, C. (1975). Regulation of nitrogen fixation. Nitrogenase-derepressed mutants of Klebsiella pneumoniae. Biochimica Et Biophysica Acta, 408(2), 101–111. https://doi.org/10.1016/0005-2728(75)90002-x
Strand, V., Pillinger, M. H., Oladapo, A., Yousefian, C., Brooks, D., & Kragh, N. (2024). Patient Experience with Chronic Refractory Gout and Its Impact on Health-Related Quality of Life: Literature Review and Qualitative Analysis. Rheumatology and Therapy, 11(5), 1271–1290. https://doi.org/10.1007/s40744-024-00697-8
Timsans, J., Palomäki, A., & Kauppi, M. (2024). Gout and Hyperuricemia: A Narrative Review of Their Comorbidities and Clinical Implications. Journal of Clinical Medicine, 13(24), 7616. https://doi.org/10.3390/jcm13247616
Yao, T.-K., Lee, R.-P., Wu, W.-T., Chen, I.-H., Yu, T.-C., & Yeh, K.-T. (2024). Advances in Gouty Arthritis Management: Integration of Established Therapies, Emerging Treatments, and Lifestyle Interventions. International Journal of Molecular Sciences, 25(19), 10853. https://doi.org/10.3390/ijms251910853
Yokose, C., McCormick, N., Abhishek, A., Dalbeth, N., Pascart, T., Lioté, F., Gaffo, A., FitzGerald, J., Terkeltaub, R., Sise, M. E., Januzzi, J. L., Wexler, D. J., & Choi, H. K. (2024). The clinical benefits of sodium–glucose cotransporter type 2 inhibitors in people with gout. Nature Reviews Rheumatology, 20(4), 216–231. https://doi.org/10.1038/s41584-024-01092-x
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
